Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Open accessAbstract
Background Long-term maintenance of weight loss remains a therapeutic challenge in obesity treatment.Objective This multicenter, double-blind, placebo-controlled study was designed to test the hypothesis that orlistat, a gastrointestinal lipase inhibitor, is significantly more effective than a placebo in preventing weight regain.Design Obese subjects who lost > or = 8% of their initial body weight during a 6-mo lead-in of a prescribed hypoenergetic diet (4180-kJ/d deficit) with no adjunctive pharmacotherapy were randomly assigned to receive placebo, 30 mg orlistat, 60 mg orlistat, or 120 mg orlistat 3 times daily for 1 y in combination with a maintenance diet to help prevent weight regain. Of 1313 recruited subjects [body mass index (in kg/m2): 28-43], 729 subjects lost > or =8% of their initial body weight during the 6-mo weight-loss lead-in period and were enrolled in the double-blind phase.Results After 1 y, subjects treated with 120 mg orlistat 3 times daily regained less weight than did placebo-treated subjects (32.8 +/- 4.5% compared with 58.7 +/- 5.8% regain of lost weight; P < 0.001). Moreover, more subjects in the 120-mg orlistat group than in the placebo group regained < or = 25% of lost weight (47.5% of subjects compared with 29.9%). In addition, orlistat treatment (120 mg 3 times daily) was associated with significantly greater reductions in total and LDL-cholesterol concentrations than was placebo (P < 0.001).Conclusion The use of orlistat during periods of attempted weight maintenance minimizes weight readjustment and facilitates long-term improvement in obesity-related disease risk factors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is evidence that antiobesity medications, including long-acting GLP-1 receptor agonists, naltrexone/bupropion, phentermine/topiramate, and orlistat, may help maintenance of achieved weight reduction.
“There is also evidence that antiobesity medications, including long-acting glucagon-like peptide-1 (GLP-1) receptor agonists, naltrexone/bupropion, phentermine/topiramate, and orlistat, may help maintenance of achieved weight reduction.5,7,8,9,10,11,12”
From Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial (2024) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137 · see citing works
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045 · see citing works
Energy and protein requirements*
Pacey, A., & Payne, P. (2019) · Routledge eBooks · doi:10.4324/9780429036279-4 · Cited by 2,545 · see citing works
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012 · see citing works
Statistical Principles in Experimental Design.
Geisser, S., & Winer, B. J. (1963) · Journal of the American Statistical Association · doi:10.2307/2283359 · Cited by 1,933 · see citing works
(1998) · PubMed · Cited by 1,264 · see citing works
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237 · see citing works
Beneficial health effects of modest weight loss.
Goldstein, D. J. (1992) · PubMed · Cited by 915 · see citing works
American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease
Eckel, R. H., & Krauss, R. M. (1998) · Circulation · doi:10.1161/01.cir.97.21.2099 · Cited by 807 · see citing works
Treatment of Obesity by Moderate and Severe Caloric Restriction: Results of Clinical Research Trials
Wadden, T. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00012 · Cited by 475 · see citing works
Is dietary fat a major determinant of body fat?
Willett, W. C. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.556s · Cited by 411 · see citing works
Multifactorial causation of obesity: implications for prevention
Grundy, S. M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.563s · Cited by 403 · see citing works
Short-Term Medical Benefits and Adverse Effects of Weight Loss
Pi-Sunyer, X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00019 · Cited by 394 · see citing works
Fat and carbohydrate overfeeding in humans: different effects on energy storage
Horton, T., Drougas, H., Brachey, A., Reed, G., Peters, J., & Hill, J. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.19 · Cited by 339 · see citing works
Self-citationINTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITY
Guy-grand, B., Crepaldi, G., Vre, P., Apfelbaum, M., Gries, A. F., & Turner, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91499-2 · Cited by 308 · see citing works
Zhi, J., Melia, A. T., Guerciolini, R., Chung, J., Kinberg, J. A., Hauptman, J. B., & Patel, I. H. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.104 · Cited by 278 · see citing works
Self-citationMason, E. E. (1992) · Obesity Surgery · doi:10.1381/096089292765560187 · Cited by 239 · see citing works
Astrup, A., Buemann, B., Christensen, N. J., & Toubro, S. (1994) · American Journal of Physiology · doi:10.1152/ajpendo.1994.266.4.e592 · Cited by 231 · see citing works
Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
Drent, M. L., Larsson, I., William-Olsson, T., QUAADE, F., Czubayko, F., von Bergmann, K., Strobel, W. M., Sjöström, L., & van der Veen, E. A. (1995) · PubMed · Cited by 208 · see citing works
Methods for Voluntary Weight Loss and Control
Panel, N. T. A. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00026 · Cited by 167 · see citing works
Lipase inhibition: a novel concept in the treatment of obesity.
Drent, M., & van der Veen, E. A. (1993) · PubMed · Cited by 151 · see citing works
Passive Overconsumption Fat Intake and Short‐Term Energy Balance<sup>a</sup>
BLUNDELL, J. E., & MACDIARMID, J. I. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51850.x · Cited by 121 · see citing works
Safer, D. J. (1991) · PubMed · Cited by 87 · see citing works
Diet, Behavior Modification, and Exercise
Safer, D. J. (1991) · Southern Medical Journal · doi:10.1097/00007611-199112000-00015 · Cited by 73 · see citing works
Flagged first, then by citations
1 of the 26 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Franz, M. J., VanWormer, J. J., Crain, A. L., Boucher, J. L., Histon, T., Caplan, W., Bowman, J. D., & Pronk, N. P. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.07.017 · Cited by 1,559 · see citing works
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041 · see citing works
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934 · see citing works
The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873 · see citing works
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876 · see citing works
Dombrowski, S. U., Knittle, K., Avenell, A., Araujo-Soares, V., & Sniehotta, F. F. (2014) · BMJ · doi:10.1136/bmj.g2646 · Cited by 816 · see citing works
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842 · see citing works
Self-citationAronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., et al. (2024) · JAMA · doi:10.1001/jama.2023.24945 · Cited by 860 · see citing works
Self-citationMeta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774 · see citing works
Behavioral treatment of obesity
Butryn, M. L., Webb, V., & Wadden, T. A. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.006 · Cited by 636 · see citing works
McTigue, K. M., Harris, R., Hemphill, B., Lux, L. J., Sutton, S. F., Bunton, A. J., & Lohr, K. N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00013 · Cited by 601 · see citing works
Obesity: Responding to the global epidemic.
Wadden, T. A., Brownell, K. D., & Foster, G. D. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.510 · Cited by 594 · see citing works
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.270.34882 · Cited by 576 · see citing works
Yanovski, S. Z., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012586 · Cited by 544 · see citing works
One-year weight losses in the Look AHEAD study: factors associated with success
Wadden, T. A., West, D. S., Neiberg, R. H., Wing, R. R., Ryan, D. H., Johnson, K. C., Foreyt, J. P., Hill, J. O., Trence, D. L., Vitolins, M. Z., et al. (2009) · Obesity · doi:10.1038/oby.2008.637 · Cited by 525 · see citing works
Self-citationShekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J. (2003) · JAMA · doi:10.1001/jama.289.12.1537 · Cited by 511 · see citing works
Inhibitory Effects of Oolong Tea Polyphenols on Pancreatic Lipase in Vitro
Nakai, M., Fukui, Y., Asami, S., Toyoda‐Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F., & Kiso, Y. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf047814+ · Cited by 493 · see citing works
LeBlanc, E. S., Patnode, C. D., Webber, E. M., Redmond, N., Rushkin, M., & O’Connor, E. A. (2018) · JAMA · doi:10.1001/jama.2018.7777 · Cited by 463 · see citing works
Medicinal strategies in the treatment of obesity
Bray, G. A., & Tartaglia, L. A. (2000) · Nature · doi:10.1038/35007544 · Cited by 432 · see citing works
Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D., Clouston, A. D., & Powell, E. E. (2004) · Gut · doi:10.1136/gut.2003.027581 · Cited by 435 · see citing works
Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck, M. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02597-w · Cited by 442 · see citing works
Zinke, I., Schütz, C. S., Katzenberger, J. D., Bauer, M. F., & Pankratz, M. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf600 · Cited by 422 · see citing works
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 456 · see citing works
LeBlanc, E. S., O’Connor, E., Whitlock, E. P., Patnode, C. D., & Kapka, T. J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-7-201110040-00006 · Cited by 401 · see citing works
Berkowitz, R. I., Wadden, T. A., Tershakovec, A. M., & Cronquist, J. L. (2003) · JAMA · doi:10.1001/jama.289.14.1805 · Cited by 389 · see citing works
Long-term pharmacotherapy for obesity and overweight
Padwal, R. S., Rucker, D., Li, S. K., Curioni, C., & Lau, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004094.pub2 · Cited by 384 · see citing works
Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
Mallinckrodt, C. H., Lane, P. W., Schnell, D. J., Peng, Y., & Mancuso, J. P. (2008) · Drug Information Journal · doi:10.1177/009286150804200402 · Cited by 358 · see citing works
Current and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 326 · see citing works
Ros, E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00456-1 · Cited by 315 · see citing works
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · see citing works
Current status of medical and surgical therapy for obesity
Mun, E. C., Blackburn, G. L., & Matthews, J. B. (2001) · Gastroenterology · doi:10.1053/gast.2001.22430 · Cited by 310 · see citing works
Orlistat: its current status as an anti-obesity drug
Ballinger, A., & Peikin, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01422-x · Cited by 296 · see citing works
AGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274 · see citing works
Hudgel, D. W., Patel, S. R., Ahasic, A. M., Bartlett, S. J., Bessesen, D. H., Coaker, M. A., Fiander, P. M., Grunstein, R. R., Gurubhagavatula, I., Kapur, V. K., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1326st · Cited by 266 · see citing works
Randomized Clinical Trials of Weight Loss Maintenance: A Review
Turk, M. W., Yang, K., Hravnak, M., Sereika, S. M., Ewing, L. J., & Burke, L. E. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317471.58048.32 · Cited by 258 · see citing works
Lipases and lipolysis in the human digestive tract: where do we stand?
Armand, M. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3280177687 · Cited by 234 · see citing works
Yoshikawa, M., Shimoda, H., Matsuda, H., Nishida, N., & Takada, M. (2002) · Journal of Nutrition · doi:10.1093/jn/132.7.1819 · Cited by 233 · see citing works
(SEEDO), S. E. P. E. E. D. L. O. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71632-0 · Cited by 221 · see citing works
Effects of Orlistat on Fat‐Soluble Vitamins in Obese Adolescents
McDuffie, J. R., Calis, K. A., Booth, S. L., Uwaifo, G. I., & Yanovski, J. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.11.814.33627 · Cited by 202 · see citing works
Feinle, C., O’Donovan, D., Doran, S., Andrews, J. M., Wishart, J. M., Chapman, I. M., & Horowitz, M. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00512.2002 · Cited by 199 · see citing works
Liu, D., Wang, F., Liao, T., Tang, J., Steglich, W., Zhu, H., & Liu, J. (2006) · Organic Letters · doi:10.1021/ol062307u · Cited by 189 · see citing works
Avenell, A., Brown, T. J., McGee, M. A., Campbell, M., GRANT, A. M., Broom, J. I., Jung, R. T., & Smith, W. C. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00530.x · Cited by 186 · see citing works
Behavioral treatment of obesity.
Kirkland, K., & Ct, M. (1983) · PubMed · Cited by 175 · see citing works
Pharmacological Treatment of the Overweight Patient
Bray, G. A., & Greenway, F. L. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.2 · Cited by 167 · see citing works
Ioannides‐Demos, L. L., Proietto, J., & McNeil, J. J. (2005) · Drugs · doi:10.2165/00003495-200565100-00006 · Cited by 165 · see citing works
Zhang, L., Li, J., Hogan, S. P., Chung, H., Welbaum, G. E., & Zhou, K. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.06.063 · Cited by 166 · see citing works
L Van Gaal for the ObelHyx Study Group, Muls, E., Kolanowski, J., Scheen, A. J., & Gaal, L. V. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801814 · Cited by 166 · see citing works
Obesity: An overview on its current perspectives and treatment options
Nammi, S., Koka, S., Chinnala, K. M., & Boini, K. M. (2004) · Nutrition Journal · doi:10.1186/1475-2891-3-3 · Cited by 163 · see citing works
Feinle, C., Rades, T., Otto, B., & Fried, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.23232 · Cited by 152 · see citing works
Richelsen, B., Tonstad, S., Rössner, S., Toubro, S., NISKANEN, L. K., Madsbad, S., Mustajoki, P., & Rissanen, A. (2006) · Diabetes Care · doi:10.2337/dc06-0210 · Cited by 147 · see citing works
Pharmacological Therapy of Obesity: Past, Present, and Future
Weigle, D. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030151 · Cited by 148 · see citing works
Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options
Fujioka, K. (2002) · Obesity Research · doi:10.1038/oby.2002.204 · Cited by 146 · see citing works
Self-citationDiagnosis and Treatment of Obesity in Adults: An Applied Evidence-Based Review
Orzano, A. J., & Scott, J. G. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.5.359 · Cited by 145 · see citing works
Obesity: A Review of Pathogenesis and Management Strategies
Kaila, B., & Raman, M. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/609039 · Cited by 128 · see citing works
Pancreatic Lipase Inhibition by C-Glycosidic Flavones Isolated from Eremochloa ophiuroides
Lee, E. M., Lee, S. S., Chung, B. Y., Cho, J., Lee, I. C., Ahn, S. R., Jang, S. J., & Kim, T. H. (2010) · Molecules · doi:10.3390/molecules15118251 · Cited by 119 · see citing works
High fat diet induces microbiota-dependent silencing of enteroendocrine cells
Ye, L., Mueller, O., Bagwell, J., Bagnat, M., Liddle, R. A., & Rawls, J. F. (2019) · eLife · doi:10.7554/elife.48479 · Cited by 118 · see citing works
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Arnold, M. E., & Steinberg, C. M. (2000) · Obesity Research · doi:10.1038/oby.2000.53 · Cited by 117 · see citing works
Obesity therapy: altering the energy intake-and-expenditure balance sheet
Crowley, V., Yeo, G. S. H., & O’Rahilly, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd770 · Cited by 116 · see citing works
Drug Treatment of the Overweight Patient
Bray, G. A., & Ryan, D. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.053 · Cited by 115 · see citing works
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004096.pub2 · Cited by 113 · see citing works
Orlistat Inhibits Dietary Cholesterol Absorption
Mittendorfer, B., Ostlund, R. E., Patterson, B. W., & Klein, S. (2001) · Obesity Research · doi:10.1038/oby.2001.79 · Cited by 114 · see citing works
Anti-obesity drugs: a critical review of current therapies and future opportunities
Clapham, J. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00105-4 · Cited by 111 · see citing works
Sahebkar, A., Simental‐Mendía, L. E., Reiner, Ž., Kovanen, P. T., Simental-Mendía, M. A., Bianconi, V., & Pirro, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.022 · Cited by 110 · see citing works
Long-Term Weight Maintenance after an Intensive Weight-Loss Program
Anderson, J. W., Vichitbandra, S., Qian, W., & Kryscio, R. J. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718897 · Cited by 110 · see citing works
Self-citationThe tumor microenvironment: shaping cancer progression and treatment response
Desai, S. A., Patel, V. P., Bhosle, K., Nagare, S. D., & Thombare, K. C. (2024) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2300224 · Cited by 112 · see citing works
Bray, G. A. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011808701117 · Cited by 105 · see citing works
Lowe, M., Miller‐Kovach, K., & Phelan, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801521 · Cited by 105 · see citing works
A systematic review of the clinical effectiveness of orlistat used for the management of obesity
O'Meara, S., Riemsma, R., Shirran, L., Mather, L., & Ter Riet, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00125.x · Cited by 103 · see citing works
Hvizdos, K. M., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199958040-00015 · Cited by 101 · see citing works
Weight management and current options in pharmacotherapy: Orlistat and sibutramine
Leung, W. Y. S., Thomas, G. N., Chan, J. C. N., & Tomlinson, B. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90009-9 · Cited by 98 · see citing works
Antiobesity action of ɛ-polylysine, a potent inhibitor of pancreatic lipase
Tsujita, T., Takaichi, H., Takaku, T., Aoyama, S., & Hiraki, J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600168-jlr200 · Cited by 97 · see citing works
Bakris, G. L., Calhoun, D. A., Egan, B. M., Hellmann, C. P., Dolker, M., & Kingma, I. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00026 · Cited by 96 · see citing works
Liu, W., Zheng, Y., Han, L.-K., Wang, H., Saito, M., Ling, M., Kimura, Y., & Feng, Y. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.07.002 · Cited by 95 · see citing works
Weight maintenance: challenges, tools and strategies for primary care physicians
Soleymani, T., Daniel, S., & Garvey, W. T. (2015) · Obesity Reviews · doi:10.1111/obr.12322 · Cited by 90 · see citing works
Orlistat in the treatment of obesity
Ballinger, A. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.4.841 · Cited by 91 · see citing works
Fabricatore, A. N., Wadden, T. A., Moore, R. H., Butryn, M. L., Gravallese, E. A., Erondu, N., Heymsfield, S. B., & Nguyen, A. M. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00567.x · Cited by 90 · see citing works
Tiikkainen, M., Bergholm, R., Rissanen, A., Aro, A., Salminen, I., Tamminen, M., Teramo, K., & Yki‐Järvinen, H. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.1.22 · Cited by 88 · see citing works
Zhou, Y.-H., Ma, X.-Q., Wu, C., Lu, J., Zhang, S.-S., Guo, J., Wu, S.-Q., Ye, X.-F., Xu, J.-F., & He, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039062 · Cited by 84 · see citing works
Orlistat: current status in clinical therapeutics
McClendon, K. S., Riche, D. M., & Uwaifo, G. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903321485 · Cited by 84 · see citing works
Yuda, N., Tanaka, M., Suzuki, M., Asano, Y., Ochi, H., & Iwatsuki, K. (2012) · Journal of Food Science · doi:10.1111/j.1750-3841.2012.02967.x · Cited by 83 · see citing works
van Baak, M. A., van Mil, E., Astrup, A. V., Finer, N., Gaal, L. F. V., Hilsted, J., Kopelman, P. G., Rössner, S., James, W. P. T., & Saris, W. H. M. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.2.209 · Cited by 83 · see citing works
Pharmacological and surgical treatment of obesity.
Shekelle, P., Morton, S. C., Maglione, M., Suttorp, M. J., Tu, W., Li, Z., Maggard, M. A., Mojica, W., Shugarman, L. R., & Solomon, V. (2004) · PubMed Central · Cited by 80 · see citing works
Topiramate: A New Potential Pharmacological Treatment for Obesity*
Astrup, A. V., & Toubro, S. (2004) · Obesity Research · doi:10.1038/oby.2004.284 · Cited by 80 · see citing works
Combining Behavioral and Pharmacological Treatments for Obesity
Phelan, S., & Wadden, T. A. (2002) · Obesity Research · doi:10.1038/oby.2002.77 · Cited by 73 · see citing works
Apovian, C. M., Garvey, W. T., & Ryan, D. H. (2015) · Obesity · doi:10.1002/oby.21140 · Cited by 72 · see citing works
Screening for anti-pancreatic lipase properties of 28 traditional Thai medicinal herbs
Dechakhamphu, A., & Wongchum, N. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2015.09.012 · Cited by 71 · see citing works
Cognitive and Behavioral Approaches in the Treatment of Obesity
Dorsten, B. V., & Lindley, E. M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.008 · Cited by 72 · see citing works
Analysis of the Accuracy of Weight Loss Information Search Engine Results on the Internet
Modave, F. P., Shokar, N. K., Peñaranda, E., & Nguyen, N. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302070 · Cited by 71 · see citing works
Karhunen, L. J., Franssila-Kallunki, A., Rissanen, P., Valve, R., Kolehmainen, M., Rissanen, A., & Uusitupa, M. I. J. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801443 · Cited by 71 · see citing works
Laaksonen, D. E., Laitinen, T. P., Schönberg, J., Rissanen, A., & NISKANEN, L. K. (2003) · Journal of Hypertension · doi:10.1097/00004872-200302000-00029 · Cited by 70 · see citing works
Bergholm, R., Tiikkainen, M., Vehkavaara, S., Tamminen, M., Teramo, K. A., Rissanen, A., & Yki‐Järvinen, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1667 · Cited by 70 · see citing works
Schroll, J. B., Penninga, E. I., & Gøtzsche, P. C. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002101 · Cited by 69 · see citing works
The effects of orlistat on metabolic parameters and other cardiovascular risk factors
Kiortsis, D. N., Filippatos, T. D., & Elisaf, M. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70161-1 · Cited by 68 · see citing works
The investigation and management of obesity
Labib, M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.17 · Cited by 65 · see citing works
Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity
Chung, H., Yu, J. G., Lee, I., Liu, M., Shen, Y., Sharma, S. P., Jamal, M. A. H. M., Yoo, J., Kim, H., & Hong, S. (2015) · FEBS Open Bio · doi:10.1002/2211-5463.12024 · Cited by 65 · see citing works
Industry funding and the reporting quality of large long-term weight loss trials
Thomas, O., Thabane, L., Douketis, J. D., Chu, R., Westfall, A. O., & Allison, D. B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.137 · Cited by 62 · see citing works
Ulen, C. G., Huizinga, M. M., Beech, B. M., & Elasy, T. A. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.3.100 · Cited by 60 · see citing works
A Functional Food Product for the Management of Weight
Bell, S. J., & Goodrick, G. K. (2002) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690290825501 · Cited by 60 · see citing works
Effect of NPY5R Antagonist MK‐0557 on Weight Regain after Very‐low‐calorie Diet‐induced Weight Loss
Erondu, N., Wadden, T. A., Gantz, I., Musser, B. J., Nguyen, A. M., Bays, H. E., Bray, G. A., O'Neil, P. M., Basdevant, A., Kaufman, K. D., et al. (2007) · Obesity · doi:10.1038/oby.2007.620 · Cited by 58 · see citing works
Self-citationObesity and Its Impact on Kidney Stone Formation.
Poore, W., Boyd, C. J., Singh, N. P., Wood, K. D., Gower, B. A., & Assimos, D. G. (2020) · PubMed Central · Cited by 55 · see citing works
- Authors
- Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J.
- Affiliations
- Scripps Health (US)
- Corresponding author
- Aronne, Louis J
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 69
- Issue
- 6
- Pages
- 1108-1116
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2166266400
- Cited by
- 287
- References
- 26
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 10
- FWCI
- 14.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- orlistat, lipase inhibitors, weight maintenance, weight regain, obesity, hypocaloric diet, long-term weight loss, LDL cholesterol, total cholesterol
- MeSH terms
- Orlistat, Adult, Behavior Therapy, Cardiovascular Diseases, Dietary Fats, Dose-Response Relationship, Drug, Double-Blind Method, Enzyme Inhibitors, Female, Humans, Lactones, Lipase, Cholesterol, HDL, Male, Obesity, Risk Factors, Weight Loss, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
